British hospitals provide a treatment for 62 % heart failure My heart
People in Britain with heart failure are given greater doses of drugs at the beginning of their treatment after a global study that this led to a significant decrease in deaths.
Experts say that the new approach may mean that those who suffer from a potential fatal condition begin to receive the amount of perfect medicines within two weeks of diagnosis and not after several months.
Evidence from other countries that have already used treatment have already found that it reduces deaths from heart failure by 62 % and reduced the risk of their end in the hospital by 30 %. That was among The main results of the strong trial HF The involvement of 87 hospitals in 14 countries.
About a million people in the UK are suffering from heart failure, which is not curable. This means that the heart is no longer able to pump blood around the body effectively and leave those with panting and tired.
St. George’s Hospital in London and Moreston Hospital in Swansea began treating patients in the innovative way, which those concerned say, “The Complete Gamechanger” says.
Clinical employees have experienced this approach – known as “fast calibration” – on how to give cancer patients a full dose of chemotherapy drugs since the beginning of their treatment to improve their chances of recovery.
“The heart failure is a silent killer, so this new way to treat patients is the game of Gamechanger completely I didn’t think I would see it in my life. It will save a lot of lives and bring hope in many families,” said Matthew Sonter, Saint George’s heart failure.
“In the past days, we will start with a very low dose and increase them in very small doses. It may take from nine to 12 months to reach the optimum dose.
“Strong-HF allowed us to think completely differently. For the first time, we offer patients a review one week after the exit and we can capture them before they get sick enough to return to the hospital.
“We can make them the recommended treatment for heart failure within two to three weeks instead of nine to 12 months.”
The global experience showed that “as soon as we create patients on these drugs, we reduce their chances of death by 62 % and the chances of reying them from heart failure by 30 %. This is huge and means that we prevent the deaths that can be avoided while relieving pressure in our hospital,” he added.
“This treatment can convert the healthy view of thousands of people with heart failure. It is another example of how NHS provides his commitment to ensure the ability to access the latest and most effective treatments to help improve the quality of their lives,” said Professor Simon Roy, the National Clinical Director of Heart of the ECG.
ST George used the approach with 14 patients who were transferred to the hospital suffering from heart failure and plans to use it with 100 other cases of this year. Moreston plans to treat 500 people from Swansea and Natet Port Talbot this way this year.
Drug patients are so strong that they will get blood pressure and check kidney function before joining their trial to assess their suitability.
“Not everyone will be eligible for this,” Shah said. “
Emily McGrath, a senior heart nurse at the British Heart Foundation, said the treatment “looks very promising.”
The government has announced its goal to reduce the deaths caused by the largest killers in Britain, such as heart disease, stroke, cancer and diabetes.
A spokesman for the Ministry of Health and Social Welfare said: “We commend the wonderful team in St. George for this extraordinary penetration that shows that NHS is at the forefront of global medical innovation,” said a spokesman for the Ministry of Health and Social Welfare.